Pharma channel feed – Endpoints News

Pharma channel feed

EMA limits use of JAK inhibitors for at-risk groups in wake of safety concerns

3 years ago

AbbVie preps for an onslaught of Humira biosimilars in 2023, with Skyrizi and Rinvoq to fill the gap for now

3 years ago

Gilead finds 'critical holes' in the government's HIV patent case against it

3 years ago

FDA loosens marketing rules for authorized Covid drugs, but will it move the needle?

3 years ago

Curia breaks ground on $100M expansion project in New Mexico

3 years ago

After months of back and forth, Mereo and its biggest stockholder reach truce, replace board members

3 years ago

As 'lower than projected' data send it back to the drawing board, Sanofi takes $1.6B hit on IL-2

3 years ago

Seagen touts progress for Padcev and Tukysa as it continues CEO search

3 years ago

Gilead's $1.7B hep D drug just ran into a roadblock at the FDA

3 years ago

Bristol Myers expands cancer survivor campaign with actor and spokesperson Sterling K. Brown

3 years ago

Merck CEO Rob Davis has business development on the brain as he builds 'pipeline of the future'

3 years ago

In next step of opioid saga, McKinsey reaches proposed agreement with school districts and local governments

3 years ago

GSK puts a 'force majeure’ on the manufacturing of a pain medicine in Pakistan

3 years ago

Alnylam blames the Inflation Reduction Act for a PhIII cut — would it have sold enough for negotiations?

3 years ago

Eli Lilly commits $92M+ to Purdue University to establish pharma manufacturing scholarship program

3 years ago

Takeda bumps Entyvio peak sales, lays out dengue vaccine plans and celiac pipeline in latest earnings call

3 years ago

Fujifilm Diosynth breaks ground on $300M expansion project in Texas

3 years ago

Adcomm offers mixed vote, recommends GSK's kidney disease drug in just one patient population

3 years ago

'Beginning of a broader loss': Pharma execs call regulators and legislators to action four months post-Roe

3 years ago

Indian site for Jubilant Generics lands Form 483 for QC issues

3 years ago

As Revlimid faces more competition, Bristol Myers' goal is to 'grow the company'

3 years ago

Aurobindo Pharma’s US branch issues a recall of a generic medicine

3 years ago

Sanofi, Regeneron take Dupixent to Broadway with latest actor celebrity spokesperson

3 years ago

Viatris and others become latest targets of Novartis' Entresto patent litigation

3 years ago

First page Previous page 164 165 166167168 169 170 Next page Last page